HCV therapy (ViroPharma/Boehringer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHCV therapy (ViroPharma/Boehringer)
Drug Alias Namehepatitis C therapy (ViroPharma/Boehringer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire Viropharma Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Viropharma IncorporatedBoehringer Ingelheim Corp
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A